Biotronik has become the world’s first manufacturer to receive European Medical Device Regulation (MDR) certification for a Class III (highest risk) medical device. Following a successful conformity assessment, the company also obtained MDR certification for its quality management system.

Class III medical devices represent the highest risk class of medical devices according to the MDR. Therefore, these devices are required to meet extensive clinical safety and performance requirements and undergo the highest level of device approval. Obtaining the first MDR certificate for a Class III medical device, according to a press release, is just the first in a series of vital steps towards MDR certification of Biotronik’s entire product portfolio

Over the past two and a half years Biotronik has developed a comprehensive company-wide project to manage the timely transition of all its medical devices as well as its quality management system into the new legal framework.

Roman Borkowski, senior vice president Quality Management and Regulatory Affairs, Cardiac Rhythm Management at Biotronik, says: “The MDR brings a complete change to the regulatory framework for medical devices in Europe that emphasises quality and safety. As a global leader in cardio- and endovascular medical technology, Biotronik has a long history of commitment to quality and safety. That is why we are very proud to be the first company to demonstrate conformity to the highest MDR risk classification. With our first MDR milestone, we are pleased to have set a precedent for the future.”

The MDR was introduced by the European Union (EU) with the aim to establish a modernised and more robust EU legislative framework to ensure better protection of public health and patient safety. The regulation will be fully applicable by May 2020.